Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with advanced kidney cancer (renal cell carcinoma) that is being treated with a standard combination of two immunotherapy drugs
- People who are willing and able to sign a written consent form agreeing to take part
Who may not be able to join:
- People whose life expectancy is less than 6 months
- People who are unable to carry out basic everyday activities such as walking
- People who have a condition affecting thinking, memory, or emotional stability — such as schizophrenia, Alzheimer's disease, or alcohol addiction — as assessed by the trial investigator
- People who have other serious health conditions that may make it difficult to do physical exercise, such as heart failure, severe lung disease, joint or bone problems, or certain neurological conditions like nerve problems, partial paralysis, amputation, or active rheumatoid arthritis — as assessed by the trial investigator
- People who are already doing structured vigorous aerobic exercise or strength training two or more times per week at a level similar to what the trial involves
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laurien M Buffart, PhD, Radboud University Medical Center
Phone: +31 24 3667310
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Participation rate; Exercise intervention adherence; Immune-related and exercise-related adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.